Cell line name |
M79 |
Accession |
CVCL_B4NR |
Resource Identification Initiative |
To cite this cell line use: M79 (RRID:CVCL_B4NR) |
Comments |
Monoclonal antibody isotype: IgG2a. Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. |
Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
Hierarchy |
Parent: CVCL_4032 (P3X63Ag8.653) |
Category |
Hybridoma |
Publications | PubMed=2427436 Gottlinger H.G., Johnson J., Riethmuller G. Biochemical and epitope analysis of the 17-1A membrane antigen. Hybridoma 5 Suppl. 1:S29-S37(1986) PubMed=3721623; DOI=10.1002/ijc.2910380109 Gottlinger H.G., Funke I., Johnson J.P., Gokel J.M., Riethmuller G. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int. J. Cancer 38:47-53(1986) PubMed=2460221 Fogler W.E., Klinger M.R., Abraham K.G., Gottlinger H.G., Riethmuller G., Daddona P.E. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen. Cancer Res. 48:6303-6308(1988) Patent=US6444207 Schoemaker H.J.P., Carrano R.A. Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen. Patent number US6444207, 03-Sep-2002 |
Cross-references |
Encyclopedic resources |
Wikidata; Q110433015
|
Entry history |
Entry creation | 16-Dec-2021 |
Last entry update | 21-Mar-2023 |
Version number | 3 |
---|